Rajajee Venkatakrishna, Fung Christopher Mon-Chee, Seagly Katharine Surella, Park Pauline Kyonsook, Raghavendran Krishnan, Machado-Aranda David Antonio, Scott Jonathan William, Delano Matthew Joseph, Abou El Ela Ashraf Shaaban Abdel Aziz, Haft Jonathan William, Williamson Craig Andrew, McSparron Jakob Israel, Blank Ross, Napolitano Lena Marie
Department of Neurosurgery, University of Michigan, Ann Arbor, MI.
Department of Neurology, University of Michigan, Ann Arbor, MI.
Crit Care Explor. 2021 Sep 10;3(9):e0537. doi: 10.1097/CCE.0000000000000537. eCollection 2021 Sep.
To prospectively describe 1-year outcomes, with a focus on functional outcome, cognitive outcome, and the burden of anxiety, depression, and post-traumatic stress disorder, in coronavirus disease 2019 patients managed with extracorporeal membrane oxygenation.
Prospective case series.
Tertiary extracorporeal membrane oxygenation center in the United States.
Adult coronavirus disease 2019 acute respiratory distress syndrome patients managed with extracorporeal membrane oxygenation March 1, 2020, to July 31, 2020.
Baseline variables, treatment measures, and short-term outcomes were obtained from the medical record. Survivors were interviewed by telephone, a year following the index intensive care admission. Functional outcome was assessed using the modified Rankin Scale and the World Health Organization Disability Assessment Scale 2.0. Cognitive status was assessed with the 5-minute Montreal Cognitive Assessment. The Hospital Anxiety and Depression Scale was used to screen for anxiety and depression. Screening for post-traumatic stress disorder was performed with the Posttraumatic Stress Disorder Checklist 5 instrument.
Twenty-three patients were managed with extracorporeal membrane oxygenation, 14 (61%) survived to hospital discharge. Thirteen (57%) were alive at 1 year. One patient was dependent on mechanical ventilation, another intermittently required supplemental oxygen at 1 year. The median modified Rankin Scale score was 2 (interquartile range, 1-2), median World Health Organization Disability Assessment Scale 2.0 impairment score was 21% (interquartile range, 6-42%). Six of 12 previously employed individuals (50%) had returned to work, and 10 of 12 (83%) were entirely independent in activities of daily living. The median Montreal Cognitive Assessment score was 14 (interquartile range, 13-14). Of 10 patients assessed with Hospital Anxiety and Depression Scale, 4 (40%) screened positive for depression and 6 (60%) for anxiety. Four of 10 (40%) screened positive for post-traumatic stress disorder.
Functional impairment was common a year following the use of extracorporeal membrane oxygenation in coronavirus disease 2019, although the majority achieved independence in daily living and about half returned to work. Long-term anxiety, depression, and post-traumatic stress disorder were common, but cognitive impairment was not.
前瞻性描述2019冠状病毒病患者使用体外膜肺氧合治疗1年的结局,重点关注功能结局、认知结局以及焦虑、抑郁和创伤后应激障碍的负担。
前瞻性病例系列研究。
美国的三级体外膜肺氧合中心。
2020年3月1日至2020年7月31日期间使用体外膜肺氧合治疗的成年2019冠状病毒病急性呼吸窘迫综合征患者。
从病历中获取基线变量、治疗措施和短期结局。在首次重症监护入院一年后,通过电话对幸存者进行访谈。使用改良Rankin量表和世界卫生组织残疾评估量表2.0评估功能结局。用5分钟蒙特利尔认知评估量表评估认知状态。使用医院焦虑抑郁量表筛查焦虑和抑郁。用创伤后应激障碍检查表5工具筛查创伤后应激障碍。
23例患者接受了体外膜肺氧合治疗,14例(61%)存活至出院。13例(57%)在1年时存活。1例患者依赖机械通气,另1例在1年时间歇性需要补充氧气。改良Rankin量表评分中位数为2(四分位间距,1 - 2),世界卫生组织残疾评估量表2.0损伤评分中位数为21%(四分位间距,6 - 42%)。12名既往有工作的患者中有6名(50%)已重返工作岗位,12名中有10名(83%)在日常生活活动中完全独立。蒙特利尔认知评估量表评分中位数为14(四分位间距,13 - 14)。在10例接受医院焦虑抑郁量表评估的患者中,4例(40%)抑郁筛查呈阳性,6例(60%)焦虑筛查呈阳性。10例中有4例(40%)创伤后应激障碍筛查呈阳性。
2019冠状病毒病患者使用体外膜肺氧合治疗1年后功能障碍很常见,尽管大多数患者在日常生活中实现了自理,约一半患者重返工作岗位。长期焦虑、抑郁和创伤后应激障碍很常见,但认知障碍并不常见。